british journal of pharmacology

Animal science journal = Nihon chikusan Gakkaiho

comparative biochemistry and physiology part b, biochemistry & molecular biology

journal of investigative medicine high impact case reports

[1] Effect of melatonin on regulation of apoptosis and steroidogenesis in cultured buffalo granulosa cells.

[2] Triple-Negative Lobular Breast Cancer Causing Hydronephrosis.

[3] Heterologous expression of concatenated nicotine acetylcholine receptors: pros and cons of subunit concatenation and recommendations for construct designs.

[4] editorial: matricellular receptors as potential targets in anti-cancer therapeutic strategies

[5] comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast comparação do grau nuclear e perfil imunoistoquímico nos componentes in situ e invasivo de carcinoma mamário

[6] mutation-prone positions within the estrogen receptor

[7] integrating data on the arabidopsis npr1/npr3/npr4 salicylic acid receptors; a differentiating argument

[8] role of laparoscopic lymphadenectomy in the management of cervical cancer

[9] corrigendum: new insights on leucine-rich repeats receptor-like kinase orthologous relationships in angiosperms

[10] An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly

[11] GABAergic currents in RT and VB thalamic nuclei follow kinetic pattern of α3- and α1-subunit-containing GABA_A receptors

[12] Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

[13] Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.

[14] Hybrid synthetic receptor composed of molecularly imprinted polydopamine and aptamers for impedimetric biosensing of urea.

[15] Gold nanoparticles conjugated to bimetallic manganese(II) and iron(II) Prussian Blue analogues for aptamer-based impedimetric determination of the human epidermal growth factor receptor-2 and living MCF-7 cells.

[16] A novel and simple method to produce large amounts of recombinant soluble peptide/major histocompatibility complex monomers for analysis of antigen-specific human T cell receptors.

[17] A adenosine receptor functional states characterized by F-NMR.

[18] Novel mutations associated with inherited human calcium-sensing receptor disorders: a clinical genetic study.

[19] Commentary: Leucine-rich Repeat Receptor-Like Gene Screen Reveals that RXEG1 Regulates Glycoside Hydrolase 12 MAMP Detection.

[20] Widely Conserved Attenuation of Plant MAMP-Induced Calcium Influx by Bacteria Depends on Multiple Virulence Factors and May Involve Desensitization of Host Pattern Recognition Receptors.

[21] [Membrane receptors recognizing MAMP/PAMP and DAMP molecules that activate first line of defence in plant immune system].

[22] Disruption of the MAMP-Induced MEKK1-MKK1/MKK2-MPK4 Pathway Activates the TNL Immune Receptor SMN1/RPS6.

[23] MAMP-triggered plant immunity mediated by the LysM-receptor kinase CERK1

[24] Membrane receptors recognizing MAMP/PAMP and DAMP molecules that activate first line of defence in plant immune system

[25] Leucine-rich repeat receptor-like gene screen reveals that Nicotiana RXEG1 regulates glycoside hydrolase 12 MAMP detection

[26] Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice.

[27] Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex.

[28] Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases.

[29] Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

[30] A Comparative Study between Co- and CoFe<inf>2</inf>O<inf>4</inf>-NPs Catalytic Activities in Synthesis of Flavone Derivatives; Study of Their Interactions with Estrogen Receptor by Molecular Docking

[31] Exploring the binding ability of phenanthroline-based polyammonium receptors for anions: hints for design of selective chemosensors for nucleotides.

[32] Exploring the binding ability of phenanthroline-based polyammonium receptors for anions: Hints for design of selective chemosensors for nucleotides

[33] Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [F]-radiolabeling and PET study in rats.

[34] Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.

[35] Discovery of 1,2,3-triazole-based fibroblast growth factor receptor modulators.

[36] Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.

[37] IR-783 Labeling of a Peptide Receptor for 'Turn-On' Fluorescence Based Sensing.

[38] Boronic Acid Appended Naphthyl-Pyridinium Receptors as Chemosensors for Sugars.

[39] A Rapid Colorimetric Sensor for Soluble Interleukin-2 Receptor α, Based on Aptamer-Adsorbed AuNP.

[40] Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs

[41] Polyamine receptors containing dipyridine or phenanthroline units: clues for the design of fluorescent chemosensors for metal ions.

[42] [N-palmitoylated peptide 232-245 of rat type 4 melanocortin receptor possessing agonistic activity].

[43] Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives.

[44] Regioselective click chemistry for construction of arylpiperazinyl 1,2,3-triazole derivative libraries as dopamine D<inf>4</inf>/D<inf>3</inf> receptor ligands

[45] Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.

[46] µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.

[47] Estrogen receptor-mediated targeting of the extracellular matrix network in cancer.

[48] Integration of Fungus-Specific CandA-C1 into a Trimeric CandA Complex Allowed Splitting of the Gene for the Conserved Receptor Exchange Factor of CullinA E3 Ubiquitin Ligases in Aspergilli.

[49] Functional Estrogen Receptors of Red Blood Cells. Do They Influence Intracellular Signaling?

[50] Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.

[51] Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB and CB receptors.

[52] Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.

[53] Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

[54] Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization

[55] Altered Central Nutrient Sensing in Male Mice Lacking Insulin Receptors in Glut4-Expressing Neurons

[56] A novel fluorescent triazole trindane-coumarin receptor for the selective detection of nitroaromatics

[57] Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones.

[58] Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

[59] Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis

[60] Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure

[61] Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

[62] Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

[63] The androgen receptor as an emerging target in hepatocellular carcinoma

[64] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

[65] Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

[66] Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

[67] Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

[68] Critical review of cancer risk associated with angiotensin receptor blocker therapy

[69] Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis

[70] Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure

[71] Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

[72] Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

[73] The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells

[74] Glucocorticoid Receptor Antagonist Administration Prevents Adrenal Gland Atrophy in an ACTH-Independent Cushing’s Syndrome Rat Model

[75] Regulation of (Pro)Renin Receptor in Renin-Positive Smooth Muscle Cells of Kidney Arterioles in Rats with STZ-Induced Diabetes

[76] The androgen receptor as an emerging target in hepatocellular carcinoma

[77] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

[78] Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

[79] Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

[80] Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

[81] C-Silylated Calix[4]Arene as a New Receptor for Aspartate in Polar Solvents

[82] Critical review of cancer risk associated with angiotensin receptor blocker therapy

[83] Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-N-(hydroxyl-O)benzamidato-O]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPARγ

[84] De Novo GRIN Variants in NMDA Receptor M2 Channel Pore-Forming Loop Are Associated with Neurological Diseases.

[85] Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.

[86] Novel class of 7-Oxabicyclo[2.2.1]heptene sulfonamides with long alkyl chains displaying improved estrogen receptor α degradation activity.

[87] Erratum: Editor's note: Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Cancer Research (2005) 65 (5009–5014))

[88] Natural Cytotoxicity Receptors: Pattern Recognition and Involvement of Carbohydrates

[89] Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7.

[90] The alpha-2 receptor agonist dexmedetomidine attenuates vancomycin‑induced acute kidney injury.

[91] Evidence for functional GABAA but not GABAC receptors in mouse cone photoreceptors.

[92] Genetic association of insulin receptor substrate-1 (IRS-1, rs1801278) gene with insulin resistant of type 2 diabetes mellitus in a Pakistani population.

[93] Patient Reported Outcomes Following Initiation of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in a Specialist Endocrinology Practice of the LMC Diabetes Registry: The PROGRESS-Diabetes Study.

[94] The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.

[95] Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin

[96] Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features

[97] The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

[98] GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

[99] Evidence-based comparison of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors.

[100] Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels

[101] Retraction notice to “Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRγ)” ((Biochemical and Biophysical Research Communications (2007) 362(1) (107–113), (S0006291X07016622), (10.1016/j.bbrc.2007.07.170))